Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Patent opposition analysis in Organic Medicines industry

In the competitive field of Organic Medicines, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Organic Medicines technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the Organic Medicines Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions
GENERICS UK180
TEVA PHARMACEUTICAL INDUSTRIES143
SANDOZ91
STADA ARZNEIMITTEL84
NUTRICIA53
HOFFMANN EITLE44
HEXAL40
ALFRED E TIEFENBACHER39
ELKINGTON AND FIFE38
SOCIETE DES PRODUITS NESTLE37

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

CompanyTotal Oppositions
NOVARTIS239
BOEHRINGER INGELHEIM97
PFIZER79
CELGENE61
NUTRICIA54
JANSSEN PHARMACEUTICA51
SOCIT DES PRODUITS NESTL49
AMGEN48
NESTEC45
EURO CELTIQUE43

Top active law firms filing patent oppositions New

Explore the top law firms that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions Filed
ELKINGTON AND FIFE265
HAMM&WITTKOPP PATENTANWALTE PARTMBB187
TER MEER STEINMEISTER & PARTNER154
D YOUNG124
HOFFMANN EITLE87
KRAUS & LEDERER PARTGMBB86
MAIWALD78
NEDERLANDSCH OCTROOIBUREAU51
HGF37
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB35

Latest patents opposed in the Organic Medicines industry

Patent challenges are becoming increasingly common in the Organic Medicines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Organic Medicines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Organic Medicines industry

EP4041186An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of PsoriasisLEO PHARMAFeb 24, 2025HGF
EP3897646Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 21, 2025SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
EP4041186An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of PsoriasisLEO PHARMAFeb 21, 2025GENERICS UK
EP4005555Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 17, 2025HAMM&WITTKOPP PATENTANWALTE PARTMBB
EP4041186An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of PsoriasisLEO PHARMAFeb 17, 2025DR SCHON
EP3773593Treatment Of Hidradenitis Suppurativa Using Jak InhibitorsINCYTEFeb 14, 2025HAMM&WITTKOPP PATENTANWALTE PARTMBB
EP3923970Methods For Increasing Growth In Pediatric Subjects Having Cholestatic Liver DiseaseMIRUM PHARMACEUTICALSFeb 14, 2025SANDOZ
EP4005555Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 14, 2025ELKINGTON AND FIFE
EP3897646Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 7, 2025SANDOZ
EP3999180Polymorphs Of (R)-N-(5-(5-Ethyl-1,2,4-Oxadiazol-3-Yl)-2,3-Dihydro-1H-Inden-1-Yl)-1-Methyl-1H-Pyrazole-4-CarboxamideCYTOKINETICSFeb 7, 2025GENERICS UK

Top patents facing oppositions in Organic Medicines industry

To stay ahead in the competitive Organic Medicines industry, companies are constantly innovating. Here are the top patents facing oppositions in the Organic Medicines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2959894Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
EP2478907Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
EP2234617Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
EP2395968Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
EP3626270Oct 11, 2023New UseNOVARTIS16
EP2962690Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
EP3294283Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS15
EP2493466Mar 10, 2021Novel Antitumoral Use Of CabazitaxelSANOFI13
EP3246021Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND12
EP3078667Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA11